Video Experimental Relacionado

Updated: Sep 12, 2025

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

Las células CAR-NK derivadas de iPSC: terapia celular para la esclerosis sistémica

May Daher¹, Katayoun Rezvani¹

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Institute for Cell Therapy Discovery & Innovation, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

|August 8, 2025

Resumen

Las células CAR-NK inducidas de células madre pluripotentes ofrecen una nueva esperanza para la esclerosis sistémica. Este enfoque puede superar las limitaciones de la terapia con células T CAR para enfermedades autoinmunes.

Área de la Ciencia:

Inmunología
Terapia con células
La Medicina Regenerativa

Sus antecedentes:

La terapia con células T receptoras del antígeno quimérico (CAR) es prometedora para enfermedades autoinmunes refractarias como la esclerosis sistémica.
La terapia de células T CAR actual se enfrenta a desafíos que incluyen toxicidades de fabricación y tratamiento personalizadas, lo que limita la aplicación generalizada.

Objetivo del estudio:

Discutir el uso clínico inicial de un producto de células madre pluripotentes inducidas (iPSC) derivado de CAR-NK para el tratamiento de la esclerosis sistémica.
Para destacar los avances en la terapia celular para las enfermedades autoinmunes.

Principales métodos:

Revisión de la aplicación clínica de un nuevo producto de células CAR-NK.
Centrarse en la tecnología iPSC para generar terapias celulares alogénicas.

Principales resultados:

El estudio informa del primer ensayo clínico de un producto de células CAR-NK derivado de iPSC en pacientes con esclerosis sistémica.
Este enfoque representa un paso significativo hacia tratamientos accesibles y estandarizados basados en células.

Conclusiones:

La terapia con células CAR-NK derivadas de iPSC ofrece una alternativa potencial a los tratamientos personalizados con células CAR-T para la esclerosis sistémica.
Esta innovación puede ampliar la accesibilidad y aplicabilidad de las inmunoterapias basadas en CAR para las enfermedades autoinmunes.

Más Videos Relacionados

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

Published on: February 1, 2013

A Novel Clinical Grade Isolation Method for Human Kidney Perivascular Stromal Cells

A Novel Clinical Grade Isolation Method for Human Kidney Perivascular Stromal Cells

Published on: August 7, 2017

Videos de Conceptos Relacionados

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...

Clinical Applications of Epidermal Stem Cells

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...